Intas Pharma Gets CDSCO Panel Nod to Conduct Phase I Trial of Pertuzumab, Trastuzumab Solution for Injection Susmita Roy26 Nov 2025 6:32 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Intas...
Abbott begins medical device correction for certain glucose monitors in US Ruchika Sharma26 Nov 2025 4:30 PM ISTAbbott Park, III: Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United...
AstraZeneca Imfinzi gets USFDA okay for early gastric and gastroesophageal cancers Ruchika Sharma26 Nov 2025 3:35 PM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin,...
Zydus Lifesciences strikes US licensing deal with RK Pharma for novel oncology supportive care injectable Ruchika Sharma26 Nov 2025 2:29 PM ISTAhmedabad: Zydus Lifesciences, a global healthcare company, has announced that it has entered into an exclusive licensing and commercialization ...
Eris Lifesciences to buy balance 30 percent stake in Swiss Parenterals for Rs 423 crore Ruchika Sharma26 Nov 2025 1:52 PM ISTMumbai: Eris Lifesciences Limited has announced that its Board of Directors has approved the acquisition of the balance 30 percent stake in Swiss...
Sanofi-Regeneron Dupixent approved in EU for chronic spontaneous urticaria Ruchika Sharma26 Nov 2025 1:00 PM ISTParis: Sanofi has announced that the European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic...
India well positioned to evolve as innovation led pharma nation over next 5 years: CDSCO Ruchika Sharma26 Nov 2025 12:29 PM ISTNew Delhi: India is well-positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five...
Bristol Myers Squibb Breyanzi secures European Commission nod for Mantle Cell Lymphoma Ruchika Sharma26 Nov 2025 11:30 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission has granted approval to Breyanzi (lisocabtagene maraleucel;...
Abbott India appoints Vinutha Mufti as new Director, Business Human Resources Ruchika Sharma25 Nov 2025 6:58 PM ISTMumbai: Abbott India has announced the appointment of Vinutha Mufti as its new Director, Business Human Resources, effective December 16,...
Bengaluru Man Spends Rs 48 Lakh on Ayurvedic Sexual-Health Drugs, Suffers Kidney Damage, Probe Underway Parthika Patel25 Nov 2025 6:22 PM ISTBengaluru: What began as a desperate search for a discreet solution to sexual-health concerns turned into a financial and medical nightmare for a...
Chief Pharmacist Served Notice Over Delayed Medicine Distribution, Lapses at Sitapur CHC Parthika Patel25 Nov 2025 5:58 PM ISTLucknow: A routine inspection turned into a major accountability drive at Sitapur's Piswa Community Health Centre (CHC) after the district magistrate...
Johnson and Johnson Told to Justify Phase III Icotrokinra Trial Design Over Sample Size, Patient Exposure Parthika Patel25 Nov 2025 5:48 PM ISTNew Delhi: Johnson & Johnson Pvt. Ltd. (JnJ) has been asked to justify key aspects of its proposed Phase III clinical trial protocol for...
